Treatment of chronic idiopathic intestinal pseudoobstruction.
D002766:Cholecystokinin / Q000627:therapeutic use; D002908:Chronic Disease; D006801:Humans; D007418:Intestinal Pseudo-Obstruction / Q000188:drug therapy*; D008297:Male; D009388:Neostigmine / Q000627:therapeutic use*; D010277:Parasympathomimetics / Q000627:therapeutic use
D010277:Parasympathomimetics; D009388:Neostigmine; D002766:Cholecystokinin